Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Wednesday preview: Central banks, Fed minutes in focus

Tue 07 Oct 2025 07:13

(Sharecast News) - Investor focus in the middle of the week will continue to be on central banks, especially the US Federal Reserve. In particular, the minutes of the Fed's most recent policy meeting are due at 1900 BST.

They will come alongside a sprinkling of Fed speakers scheduled for throughout the afternoon.

The results of the latest auction of 10-year US treasuries, at 1900 BST, may also prove to be a talking point.

In the UK, the minutes of the Financial Policy Committee's last meeting will be released at 1130 BST.

Bank of England chief economist will deliver a speech at 1600 BST, followed by European Central Bank president Christine Lagarde at 1700 BST.

Across the Channel, German industrial production data for August will come out at 0700 BST.

Overnight, rate-setters in New Zealand will meet to decide on interest rates.

Wednesday 08 October

INTERIMS

Vertu Motors

INTERNATIONAL ECONOMIC ANNOUNCEMENTS

Crude Oil Inventories (US) (15:30)

Industrial Production (GER) (07:00)

MBA Mortgage Applications (US) (12:00)

FINALS

Netcall

AGMS

Diverse Income Trust (The), European Opportunities Trust, ITM Power

FINAL DIVIDEND PAYMENT DATE

Dr. Martens

Share this article

Related Sharecast Articles

Fri 17 Jul 2026 12:40
ConocoPhillips to buy 42% stake in BP Iraq oil fields
(Sharecast News) - BP said on Friday that it has agreed terms for ConocoPhillips to buy a 42% interest in BP Energy Company of Kirkuk (BP ECKL).
Fri 17 Jul 2026 11:29
GSK shares fall as cough drug development axed
(Sharecast News) - Shares in GSK fell sharply on Friday after the pharma titan announced it was stopping the development of a refractory chronic cough drug after unsuccessful results late-stage clinical trial.
Fri 17 Jul 2026 11:26
Deutsche Bank downgrades Rotork after ABB takeover
(Sharecast News) - Deutsche Bank downgraded Rotork on Friday to 'hold' from 'buy' and lifted the price target to 503p from 400p after it agreed to be bought by Swiss engineering firm ABB in a £4.1bn deal.
Fri 17 Jul 2026 09:30
Wise Q1 revenues rise as customer numbers grow
(Sharecast News) - Wise reported an increase in first-quarter revenue on Friday as customer numbers at the money transfer firm rose.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Policies and important information
 

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme

 

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026